About this trial
Home Treatment (HT) has been successfully implemented in adult psychiatry in several countries including Switzerland. Patients with addiction problems were generally excluded even if the latter was not the main diagnosis. On the other hand, community treatments have successfully been established for these individuals. The investigators have recently offered HT to persons with severe addictive disorders which was well accepted.
The investigators intend to conduct a pilot study to prepare a large-scale study if successful. The investigators intend to compare HT to treatment as usual (regular inpatient treatment) on a specialized ward with respect to readmission rates during 6 months after discharge. The data show that 70.8% of all readmissions occur during the first 6 months. Therefore, a period of 6 months is considered an adequate time interval to sufficiently answer this pilot study's question.
Eligibility criteria
Qualifiers
Substance use disorder
age 18 or above
sufficient french language skills
competent subjects
Disqualifiers
organic brain disease or developmental disorder
non voluntary admission
severe somatic comorbidity
History of complicated substance withdrawal
Trial design
Treatments tested in this trial
- Hospital-like treatment in patients' home
- standard inpatient treatment
Treatment groups
Sponsors and collaborators
Louise Penzenstadler
Lead sponsor
University Hospital, Geneva
Sponsor institution